Phase II evaluation of bisantrene in patients with renal cell carcinoma

Cancer Treat Rep. 1982 Oct;66(10):1869-71.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Anthracenes / therapeutic use
  • Anthracenes / toxicity
  • Antibiotics, Antineoplastic / therapeutic use*
  • Antibiotics, Antineoplastic / toxicity
  • Bone Neoplasms / drug therapy
  • Drug Evaluation
  • Female
  • Humans
  • Leukocyte Count
  • Liver Neoplasms / drug therapy
  • Lung Neoplasms / drug therapy
  • Male
  • Middle Aged

Substances

  • Anthracenes
  • Antibiotics, Antineoplastic
  • bisantrene